Revolution Medicines, Inc. — insider transactions
10 transactions on record · CIK 1628171
Aggregates
computed from the filings belowPurchases, 12m
0
count of open-market buys
Sales, 12m
10
count of open-market sales
Buy / sell ratio, 12m
0.00
purchases per sale
Distinct insiders, 12m
1
Bought, 3m
$0
Sold, 3m
$13M
Median disclosure lag
4.0 d
trade date to filing date
Largest single trade, 24m
$5.4M
2026-08-21
Director share, 12m
0.0%
of transactions where role is stated
Current run
10 sells
consecutive same-direction transactions
Net 3m flow
-$13M
purchases minus sales
Total on record
10
Transactions
10 most recent shown| Disclosed | Traded | Lag, d | Insider | Role | Transaction | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-25 | 2026-08-21 | 4 | Cislini Jeff | General Counsel | Exercise of derivative | 26,600 | $21.61 | $574.8K | filing |
| 2026-08-25 | 2026-08-21 | 4 | Cislini Jeff | General Counsel | Open market sale | 25,817 | $209.25 | $5.4M | filing |
| 2026-08-25 | 2026-08-21 | 4 | Cislini Jeff | General Counsel | Open market sale | 3,314 | $212.06 | $702.8K | filing |
| 2026-08-25 | 2026-08-21 | 4 | Cislini Jeff | General Counsel | Open market sale | 3,400 | $207.24 | $704.6K | filing |
| 2026-08-25 | 2026-08-21 | 4 | Cislini Jeff | General Counsel | Open market sale | 2,540 | $210.26 | $534.1K | filing |
| 2026-08-25 | 2026-08-21 | 4 | Cislini Jeff | General Counsel | Exercise of derivative | 29,680 | $0.00 | — | filing |
| 2026-08-25 | 2026-08-21 | 4 | Cislini Jeff | General Counsel | Exercise of derivative | 29,680 | $18.56 | $550.9K | filing |
| 2026-08-25 | 2026-08-21 | 4 | Cislini Jeff | General Counsel | Open market sale | 17,323 | $208.37 | $3.6M | filing |
| 2026-08-25 | 2026-08-21 | 4 | Cislini Jeff | General Counsel | Open market sale | 4,500 | $211.34 | $951K | filing |
| 2026-08-25 | 2026-08-21 | 4 | Cislini Jeff | General Counsel | Exercise of derivative | 26,600 | $0.00 | — | filing |